Journals / Kocatepe Veteriner Dergisi / 2013 / Cilt: 6 - Sayı: 1

İnsan ve Hayvanlarda Kalp Hastalıklarının Tedavisinde Bitkisel İlaçların Etkinliği

Efficacy of Herbal Remedies in The Treatment of Cardiovasculer Diseases in Human and Animals

Pages
63–68
Publication Date
2013-03-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review provides important knowledge both insights on issues concerning the safety of the most commonly used dietary supplements and nutraceuticals with demonstrated lipid-lowering actions and their applicability in the field of veterinary medicine

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cardiovascular diseases are the most important causes of death and organ failure in industrialized countries.
📊
Key Findings & Data:There is widespread use of herbal treatments in patients suffering from cardiovascular diseases all over the world.
💡
Conclusion & Impact:This review provides important knowledge both insights on issues concerning the safety of the most commonly used dietary supplements and nutraceuticals with demonstrated lipid-lowering actions and their applicability in the field of veterinary medicine
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Kardiyovazküler Hastalıklar

Abstract

Cardiovascular diseases are the most important causes of death and organ failure in industrialized countries. There is widespread use of herbal treatments in patients suffering from cardiovascular diseases all over the world. The discussion about the benefit of these drugs is still controversial because of lack of scientific evidence. Lifestyle interventions, including dietary supplement with natural compounds possessing known lipid-lowering effects, are strongly supported by the international guidelines for cardiovascular disease prevention. This review provides important knowledge both insights on issues concerning the safety of the most commonly used dietary supplements and nutraceuticals with demonstrated lipid-lowering actions and their applicability in the field of veterinary medicine

Özet

Kardiyovazküler hastalıklar sanayileşmiş ülkelerde ölüm ve organ yetersizliklerinin en önemli nedenidir. Dünya çapında kardiyovazküler hastalıklardan müzdarip hastalarda bitkisel tedaviler yaygın olarak kullanılmaktadır. Bu ilaçların faydaları hakkındaki tartışmalar, bilimsel verilerin yetersizliği nedeniyle hala tartışma konusudur. Lipid düşürücü etkileri nedeniyle diyetlere bileşiklerin eklenmesini içeren yaşam tarzı, kardiyovazküler hastalıklardan korunmak için uluslar arası otoriteler tarafından şiddetle önerilmektedir. Bu derleme, en yaygın kullanılan lipid düşürücü etkili nütrasötikler ve diyet ilave ürünleri ve veteriner hekimlik alanında uygulanabilirliği hakkında önemli bilgiler sağlamaktadır

🔖

Cite This Article

ELİTOK, B. (2013). İnsan ve Hayvanlarda Kalp Hastalıklarının Tedavisinde Bitkisel İlaçların Etkinliği. Kocatepe Veteriner Dergisi, Cilt: 6 - Sayı: 1, 63–68. https://ajindex.com/articles/125020

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Agarwal KC. 1996. Therapeutic actions of garlic constituents. Med Res Rev. 16(1):111-24. Aviram M. Dornfeld L. Rosenblat M. Volkova N. Kaplan T. Presser Pomegranate juice consumption reduces B. 2000. BE. Zineh I. Hwang HS. Welder GJ. Ghannam MM. Boluyt MO. 2007. Evaluation immunomodulatory biomarkers in a pressure overload model of heart failure. Med Sci Monit. 13(12):255-8. extract on Chan JY. Yuen AC. Chan RY. Chan SW. 2012. A Review of the Cardiovascular Benefits and Antioxidant Properties of Allicin. Phytother Res. Published online in Wiley Online Library (wileyonlinelibrary.com) Clement Y. 2009. Can green tea do that? A literature review of the clinical evidence. Prev Med. 49(2-3):83-7. Daniele C. Mazzanti G. Pittler MH. Ernst E. 2006. Adverse-event profile of Crataegus spp.: a systematic review. Drug Saf. 29(6):523-35. Davidson MH. Maki KC. Dicklin MR. Feinstein SB. Witchger DK. Provost JC. Liker H. 2009. Aviram M. Effects of consumption of pomegranate juice on carotid intima-media thickness in men and women at moderate risk for coronary heart disease. Am J Cardiol. 104(7):936-42. Hao Y. Sun Y. Xu C. Jiang X. Sun H. Wu Q. Yan C. Gu S. 2009. Improvement of contractile function in isolated cardiomyocytes from ischemia-reperfusion rats by ginkgolide B pretreatment. J Cardiovasc Pharmacol. 54(1):3-9. Hassanpour FM. Ghule AE. Bodhankar SL. Dikshit M. 2011. Cardioprotective effect of whole fruit extract of pomegranate on doxorubicin-induced toxicity in rat. Pharm Biol. 49(4):377-82. Hsieh SR. Tsai DC. Chen JY. Tsai SW. Liou YM. 2009. Green tea extract protects rats against myocardial infarction associated with left anterior descending coronary artery ligation. Pflugers Arch. 458(4):631-42. Ikeda M. Suzuki C. Umegaki K. Saito K. Tabuchi M. Tomita T. 2007. Preventive effects of green tea catechins on spontaneous stroke in rats. Med Sci Monit. 13(2):40-5. Jadeja RN. Thounaojam MC. Patel DK. Devkar RV. Ramachandran AV. 2010. Pomegranate (Punica granatum L.) juice supplementation attenuates necrosis in rats. Cardiovasc Toxicol. 10(3):174-80. cardiac Kuriyama S. 2010. Green tea consumption and prevention of coronary artery disease. Circ J. 74(2):248-9. Layu M. Bhushan S. Lefer DJ. 2011. Hydrogen sulfide-mediated mechanisms and therapeutic potential. Clin Sci (Lond). 120(6):219-29. cardioprotection: Liu A. Zhang Z. 2010. Effect of GBE50 on action potentials in normal and simulated ischemic guinea pig papillary muscles. Zhongguo Zhong Yao Za Zhi. 35(17):2342-5. Li